Immunocore Holdings IMCR Cash Flow Statement (2021-2026)

NASDAQ IMCR
$32.60 +2.76 (+9.25%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Immunocore Holdings Quarterly Cash Flow Statement

Periods 19 quarters
Latest Jun 2026

Immunocore Holdings reported cash from operations of $15.93M and free cash flow of $15.14M for the quarter ended Jun 2026, down 38.7% year over year. This cash flow statement covers 19 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -41.54M-53.10M-20.31M7.34M-29.56M-19.45M-17.01M0.91M-19.73M-24.44M-11.62M8.74M-23.77M5.02M-10.30M-0.18M-30.06M12.97M-0.81M
Depreciation and DepletionDep. & Depletion 2.32M1.74M1.57M0.95M1.03M1.08M1.03M1.01M0.99M1.04M1.17M0.85M0.78M0.80M0.83M0.95M1.03M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 2.32M1.74M1.57M0.95M1.03M1.08M1.03M1.01M0.99M1.04M1.17M0.85M0.78M0.80M0.83M0.95M1.03M
Share-based CompensationStock Comp. 12.68M11.76M9.34M7.18M8.06M8.26M8.75M8.20M7.19M8.96M10.00M6.56M8.67M9.49M10.03M9.84M8.34M6.30M9.40M
Gains from Investment SecuritiesGains Investment 4.61M8.90M1.09M5.50M4.70M5.02M4.50M1.80M3.05M
Other non-cash itemsOther Non-Cash 2.02M-12.22M17.92M7.62M4.64M-10.85M14.49M1.73M1.49M-4.31M9.30M-1.85M3.41M-8.53M5.05M-2.33M1.96M
Non-cash ItemsNon-Cash Items -0.17M-0.19M1.62M
Change in Working Capital
Change in ReceivablesChange Receivables 4.67M5.98M8.29M3.58M3.60M0.47M10.22M6.20M2.66M2.19M1.30M-0.84M4.18M5.99M-1.99M7.93M14.62M
Change in Account PayablesChange Payables 8.61M18.89M13.19M-3.02M5.98M-4.09M3.76M-2.32M4.48M-0.78M5.88M3.34M-6.93M-0.29M1.42M5.97M-4.80M
Change in Accured ExpensesChange Accured Exp. 4.58M7.30M11.23M15.98M19.17M26.86M26.70M-1.23M-10.94M33.73M15.13M-22.03M-8.30M27.00M
Change in Other Operating AssetsOther Assets Change -18.10M5.97M-3.24M16.00M3.21M0.75M6.46M5.40M1.60M-5.49M11.09M5.72M18.62M-1.34M
Change in Other Operating LiabilitiesOther Liabilities Change -5.76M-5.03M0.07M-2.92M-1.14M0.85M-8.38M0.70M-1.84M1.88M-2.39M0.76M-1.38M0.91M-2.76M-1.01M-1.51M
Other Working Capital ChangesOther WC Changes -5.76M-5.03M0.07M15.18M-7.11M4.09M-24.38M-2.51M-2.59M-4.58M-7.79M-0.85M4.11M-10.18M-8.48M-19.63M-0.16M
Cash from OperationsCash from Ops. -22.02M9.54M7.08M10.54M0.05M10.09M-17.73M-4.59M23.47M21.13M-13.95M0.44M25.96M-4.46M-32.66M-13.78M15.93M
Investing Activities
Capital ExpendituresCapex 0.37M0.46M1.08M3.00M1.40M0.21M0.82M0.43M0.33M0.83M3.58M0.30M0.41M0.75M2.88M1.78M0.79M
Sales of Property, Plant and EquipmentPP&E (Sale) 0.02M
Change in Property, Plant and EquipmentChange in PP&E -0.36M-0.46M-1.08M-3.00M-1.40M-0.21M-0.82M-0.43M-0.33M-0.83M-3.58M-0.30M-0.41M-0.75M-2.88M-1.78M-0.79M
Sale and Maturity of InvestmentsInvestments Sold 10.00M6.00M2.00M6.00M
Other Investing ActivitiesOther investing 0.70M1.95M
Cash from Investing ActivitiesCash from Investing -0.36M0.24M0.39M-3.00M-1.40M-0.21M-0.82M-0.43M-350.33M-0.83M-3.54M9.70M-30.41M5.25M-0.88M4.22M-0.79M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 402.50M
Long-Term Debt RepaymentsLT Debt Repayment 2.26M51.71M
Non-Current Debt -2.26M-51.71M402.50M
Net Debt Issuances and RepaymentsNet Debt Issuance -2.26M-51.71M402.50M
Change in Capital Stock
Common Stock IssuedStock Issued 0.42M141.38M4.23M6.14M11.58M10.38M6.25M5.75M0.30M0.20M0.55M2.55M3.67M1.87M4.28M0.66M16.49M
Net Shares Issued and RepurchasedNet Shares Issued 0.42M141.38M4.23M6.14M11.58M10.38M6.25M5.75M0.30M0.20M0.55M2.55M3.67M1.87M4.28M0.66M16.49M
Net Equity Issued and RepurchasedNet Equity Issued 0.42M141.38M4.23M6.14M11.58M10.38M6.25M5.75M0.30M0.20M0.55M2.55M3.67M1.87M4.28M0.66M16.49M
Other financing activitiesOther financing -0.94M-1.42M-1.11M-12.24M-1.12M-2.06M
Cash from Financing ActivitiesCash from Financing -2.78M138.50M-1.40M6.14M11.58M10.38M6.25M396.01M-0.82M0.20M-51.51M2.55M3.67M1.87M4.28M0.66M16.49M
Additional items
Exchange Rate EffectFX Effect -0.01M15.69M-23.25M2.23M3.39M-8.11M10.78M-0.80M-0.16M12.29M-13.03M8.43M11.87M7.82M-1.45M-6.13M0.62M
Change in Cash -25.15M148.28M6.07M13.68M10.23M20.25M-12.30M391.00M-327.68M20.50M-69.00M12.69M-0.78M2.66M-29.25M-8.90M31.63M
Ending Cash Balance 402.47M418.38M432.00M444.14M442.63M832.82M504.99M537.77M455.73M476.85M487.93M498.41M467.71M452.68M484.92M
Free Cash FlowFCF -22.39M9.07M6.00M7.54M-1.35M9.88M-18.55M-5.02M23.14M20.30M-17.54M0.14M25.55M-5.20M-35.54M-15.56M15.14M
Net Cash FlowNCF -25.15M148.28M6.07M13.68M10.23M20.25M-12.30M391.00M-327.68M20.50M-69.00M12.69M-0.78M2.66M-29.25M-8.90M31.63M
Interest Paid 6.27M5.03M5.03M5.03M
Income Taxes PaidTaxes Paid 16.69M-0.72M0.00M-0.22M0.44M0.76M0.14M-0.08M0.29M0.16M0.03M1.48M2.08M1.06M0.01M0.74M

Immunocore Holdings Cash Flow Statement API

Pull Immunocore Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMCR&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY